United States v. Conner’s Empirical Analysis
2005
Citation profile
Relationships
Applies 18 U.S.C. § 3742 · 21 U.S.C. § 856 (§ 416 of the Controlled Substances Act) · 21 U.S.C. § 865 · 28 U.S.C. § 1291
Relies on United States v. Booker · Blakely v. Washington · Williams v. United States · United States v. Jones · United States v. Riccardi
Most-quoted passages
The sentences later courts lift from this opinion, ranked by how many decisions quote each — the parts of the opinion doing the work. These counts are smaller than the citation total above because most of the 1 citing decisions cite the case generally; a passage count includes only decisions quoting that exact language verbatim.
“We do pause, however, to note our particular concern with the district court’s attribution of 8,640 milligrams of pseu-doephedrine to Mi\ Conner. Our review of the record reveals that evidence of this quantity was not presented during the trial and the issue was a subject of heated dispute in the sentencing hearing. Moreover, the evidence provided by the government at the sentencing hearing did not clearly indicate whether the calculation of the quantity of pseu-doephedrine included the weight of the entire tablets or just the pseudoephed-rine contained in the tablets.”
1 later decision quote this exact passage · from the majority
How this case has been treated — in progress
Whether each later court followed, distinguished, criticized, or overruled this decision. The treatment classification (task #35) runs highest-cited cases first and lights up here as it reaches this one.